CAMX:STO
Camurus AB
729,50 SEK
arrow_downward
-1,42%(-10,50) 1D
17 նոյ, 17:29:44 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
736,00 SEK
High
739,00 SEK
Low
724,50 SEK
Mkt. cap
44,81 մլրդ
Avg. vol.
107,44 հզր
Volume
85,16 հզր
52-wk high
750,00 SEK
52-wk low
430,80 SEK
Shares outstanding
60,56 մլն
No. of employees
323
Open
736,00 SEK
High
739,00 SEK
Low
724,50 SEK
Mkt. cap
44,81 մլրդ
Avg. vol.
107,44 հզր
Volume
85,16 հզր
52-wk high
750,00 SEK
52-wk low
430,80 SEK
Shares outstanding
60,56 մլն
No. of employees
323
News stories
From web sources and news partners
ChartMill
·
1 ժամ առաջ
S&P 500 After-Hours Gainers for Nov. 17, 2026
BigGo Finance
·
41 րոպե առաջ
New York Stocks Slip a Day Before Nvidia Earnings; S&P 500, Nasdaq Fall for Fourth Straight Session
BigGo Finance
·
1 ժամ առաջ
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
Traders Union
·
2 ժամ առաջ
Ryan Detrick: Technology stocks outperformed S&P 500 while 75 stocks declined
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB